Recent decades have witnessed remarkable advancements in the treatment of muscular dystrophy. Experts are actively investigating innovative approaches that hold potential for enhancing the lives of individuals living with this degenerative illness. Drug development have emerged as particularly effective avenues for addressing the underlying roots o